#Spain #Madrid #Cardiac Technology #Corify Care #Global Volumetric Mapping

Corify Care Introduces Groundbreaking Whole-Heart Mapping Technology

In a significant advancement for cardiac healthcare, Corify Care recently announced the launch of its innovative Global Volumetric Mapping technology, detailed in the journal Nature Communications Medicine. This revolutionary system stands out as the first of its kind capable of mapping all four chambers of the heart simultaneously, granting physicians an unparalleled, real-time overview of arrhythmias that existing technologies fail to provide.

Transforming Electrophysiology

Traditionally, mapping systems have focused on analyzing one heart chamber at a time. This limitation often forces medical professionals to make inferences about arrhythmias based on incomplete data. With Corify Care's new system, the dynamics of the heart can be visualized throughout the entire organ, both on the surface and inside its walls, including the septum. This holistic approach enables the creation of a comprehensive cardiac map in a single heartbeat—an essential development for improving diagnostic accuracy and treatment effectiveness.

Dr. Andreu Climent, the CEO of Corify Care, emphasizes, "This technology enhances visibility and boosts physician confidence. By providing a complete picture, clinicians can make faster decisions and conduct more targeted ablations, ultimately resulting in reduced procedure complexities and improved patient care."

Elevating EP Labs to New Heights

Designed with the Electrophysiology (EP) Lab of the future in mind, Corify's Global Volumetric Mapping technology identifies arrhythmia circuits that conventional mapping often overlooks. This includes circuits deep within myocardium and those that extend across multiple heart chambers. By eliminating such blind spots, the innovative platform equips doctors with tools to tackle intricate cases more efficiently and predictably. According to Dr. Felipe Atienza, Chief Medical Officer, "For the first time, we can non-invasively observe the heart's true behavior on a global scale, which significantly influences workflow, outcomes, and scalability in EP labs."

Advancements in Clinical Applications

Highlighting the importance of this volumetric approach, Dr. Jorge Vicente-Puig, the lead author of the study, adds, "Our research shows that a volumetric methodology is critical for accurate arrhythmia characterization. By moving beyond the mathematical limitations of prior technologies, we can now offer a complete three-dimensional physiological picture of the heart."

The ACORYS® system, which has already received the CE Mark, is under review by the FDA to comply with the regulatory standards for the U.S. market. Corify is also diligently working to integrate its technology with dominant catheter navigation platforms, facilitating a seamless hybrid workflow that streamlines procedural processes.

Looking Ahead: Clinical Presentations and Future Directions

Exciting developments are on the horizon, as Corify Care plans to present new clinical data regarding the application of its Global Volumetric Mapping technology for conditions like Atrial Fibrillation and Ventricular Tachycardia at the upcoming 2026 AF Symposium in Boston.

In summary, Corify Care is at the forefront of redefining cardiac mapping. Its novel, non-invasive technology for comprehensive heart visualization aims to help clinicians tackle complex arrhythmias with unprecedented confidence and efficacy. As this groundbreaking technology continues to evolve, it holds the promise of transforming the landscape of cardiac electrophysiology for years to come.